Existing drug mitigates muscle loss from GLP-1 medications
View as a Web Page
News Medical
 
  Rheumatology Rheumatology logo  
  The latest rheumatology news from News Medical  
 $2 million NIH funding supports wearable knee exoskeleton research$2 million NIH funding supports wearable knee exoskeleton research
 
Building on the success of projects to boost strength by adding motors to conventional knee, hip and ankle braces, a University of Michigan team is exploring how well this approach could work for relieving knee pain from osteoarthritis.
 
 
 Existing drug mitigates muscle loss from GLP-1 medicationsExisting drug mitigates muscle loss from GLP-1 medications
 
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss.
 
   Pim1 identified as promising therapeutic target for inflammatory arthritis treatment
 
The research team led by Professor Zhongyu Xie from Sun Yat-sen University revealed a new mechanism by which Pim1 regulated Th17 cell differentiation through mitochondrial metabolism.
 
   New study reveals barriers to Medicaid-funded home care accessNew study reveals barriers to Medicaid-funded home care access
 
Obtaining home care for older adults with Medicaid can be a complex, multi-step process marked by delays and uncertainty, often resulting in long wait times, according to a new Weill Cornell Medicine study.
 
 Anti-inflammatory drug tocilizumab shows promise for difficult-to-treat depression
 
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical trial, published in JAMA Psychiatry today [20 May].
 
 
 Graph neural networks accelerate drug discovery for complex bone diseases
 
Announcing a new publication for Acta Materia Medica journal. Traditional Chinese medicine has shown therapeutic potential in treating osteoarthritis (OA) by regulating inflammation and maintaining cartilage homeostasis.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026